Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.42

+0.1%

Dec 1 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Russian Bear who wrote (73)	8/23/1998 6:59:00 PM
From: scaram(o)uche	Read Replies (1) of 1475

RB: Thanks, good stuff. From the bio for Andrew Mellor...... "We are exploring the possibility that certain macrophages can develop the capacity to inhibit T cell responses by a novel mechanism that involves nutrient depletion in local tissue microenvironments." I actually followed his work quite closely, on two fronts... Qa-2 and H-2D antigen expression on murine tumors, several years ago. He collaborated with Dan Merulo and their work was key for some stuff that I was interested in. He's been up to his eyeballs in the major histocompatibility complex, so it should be interesting to see what this "chemical" is. I can't find anything in recent abstracts that gives me a clue. The CNN report is sort of lame... it's good to simplify for the layman, but failing to mention the agent?? Thanks! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next